Latest filing published 11 May 2011 for Incyte Corp, €214k.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +158.2%Entry US$2.92 · Close at T+365 US$7.54
- +77.7%Entry US$3.95 · Close at T+365 US$7.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Patricia A. Schreck: trading record in brief
All filings by Patricia A. Schreck on record concern Incyte Corp. Between 4 April 2006 and 10 May 2011, the trades on record add up to 27 filings.
Both buying and selling appear: 2 purchases worth €11k, against 20 sales worth €3.6M. Taken together, the sales exceed the purchases by €3.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 5 option exercises. In 2011 alone, the filings show no purchases and 7 sales.
The latest filing, published on 11 May 2011, reports an option exercise of €214k in Incyte Corp. The clock since the last published purchase (21 November 2008) now reads 6,562 days. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Patricia A. Schreck
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$6.15Common StockSEC:0001181431-11-028835:0
- 50,000 shares@ US$19.90Common StockSEC:0001181431-11-028835:1
- 50,000 shares@ US$5.46Common StockSEC:0001181431-11-028835:2
- 10,000 shares@ US$20.50Common StockSEC:0001181431-11-028835:3
- 10,000 shares@ US$20.51Common StockSEC:0001181431-11-028835:4
- 10,000 shares@ US$20.57Common StockSEC:0001181431-11-028835:5
- 10,000 shares@ US$20.66Common StockSEC:0001181431-11-028835:6
- 10,000 shares@ US$20.67Common StockSEC:0001181431-11-028835:7
- 30,468 shares@ US$5.46Common StockSEC:0001181431-11-023223:0
- 69,532 shares@ US$3.11Common StockSEC:0001181431-11-023223:1
- 100,000 shares@ US$16.50Common StockSEC:0001181431-11-023223:2
- 94,960 shares@ US$6.15Common StockSEC:0001181431-10-041194:0
- 4,505 shares@ US$13.84Common StockSEC:0001181431-10-041194:1
- 6,200 shares@ US$13.85Common StockSEC:0001181431-10-041194:2
- 6,000 shares@ US$13.86Common StockSEC:0001181431-10-041194:3
- 13,430 shares@ US$13.90Common StockSEC:0001181431-10-041194:4
- 1,499 shares@ US$13.83Common StockSEC:0001181431-10-041194:5
- 600 shares@ US$13.80Common StockSEC:0001181431-10-041194:6
- 25,885 shares@ US$13.88Common StockSEC:0001181431-10-041194:7
- 1,360 shares@ US$13.81Common StockSEC:0001181431-10-041194:8
- 7,800 shares@ US$13.91Common StockSEC:0001181431-10-041194:9
- 492 shares@ US$13.82Common StockSEC:0001181431-10-041194:10
- 7,689 shares@ US$13.87Common StockSEC:0001181431-10-041194:11
- 10,600 shares@ US$13.92Common StockSEC:0001181431-10-041194:12
- 8,900 shares@ US$13.89Common StockSEC:0001181431-10-041194:13
25 of 27 declarations
